COMBINATION OF TYROSINE CHINASE INHIBITORS AND CHEMICAL CASTRATION FOR THE TREATMENT OF PROSTATE CANCER

摘要

A method of treating prostate cancer by co-administering a tyrosine kinase inhibitor such as an indolocarbazole and a chemical castration agent is disclosed. A composition containing a tyrosine kinase inhibitor and a chemical castration agent is also disclosed.